Article
Human papillomavirus self‐sampling with mRNA testing benefits routine screening
18 Jun 2022
Abstract excerpt
High risk human papillomavirus (hrHPV) based screening provides the possibility of vaginal self-sampling as a tool to increase screening attendance. In order to evaluate the impact and feasibility of opt-in self-sampling in the Finnish setting, we invited a randomized population of 5350 women not attending screening after age group invitation or after reminder, to attend HPV self-sampling-based screening in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
